Original language | English |
---|---|
Journal | Rheumatology |
Early online date | 13 Aug 2018 |
DOIs | |
Publication status | E-pub ahead of print - 13 Aug 2018 |
Keywords
- anti-PD-1
- anti-PD-L1
- pembrolizumab
- melanoma
- immune-related adverse event
- arthritis
Mark Ford, Ilfita Sahbudin, Andrew Filer, Neil Steven, Benjamin Fisher
Research output: Contribution to journal › Article › peer-review
Original language | English |
---|---|
Journal | Rheumatology |
Early online date | 13 Aug 2018 |
DOIs | |
Publication status | E-pub ahead of print - 13 Aug 2018 |